KDA Group, Inc.

  • Market Cap: N/A
  • Industry: Tour, Travel Related Services
  • ISIN: CA48669F1071
CAD
0.25
0.02 (6.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Tour, Travel Related Services

stock-summary
Market cap

CAD 46 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.00

stock-summary
Return on Equity

-72.08%

stock-summary
Price to Book

4.61

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Apr 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.28%
0%
-12.28%
6 Months
-7.41%
0%
-7.41%
1 Year
-31.51%
0%
-31.51%
2 Years
233.33%
0%
233.33%
3 Years
212.5%
0%
212.5%
4 Years
66.67%
0%
66.67%
5 Years
38.89%
0%
38.89%

KDA Group, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-64.37%
EBIT Growth (5y)
-229.08%
EBIT to Interest (avg)
-2.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.39
Tax Ratio
1.57%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.38%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.52
EV to EBIT
-5.83
EV to EBITDA
-9.75
EV to Capital Employed
4.52
EV to Sales
45.24
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-77.47%
ROE (Latest)
-72.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is -100.00% vs 0.00% in Jan 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 4.76% vs 12.50% in Jan 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.30",
          "val2": "-1.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.00",
          "val2": "-2.10",
          "chgp": "4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-158,553.50%",
          "val2": "-26,430.20%",
          "chgp": "-13,212.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jul'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jul 2024 is -50.00% vs 0.00% in Jul 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jul 2024 is -1,350.00% vs 106.67% in Jul 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jul'24",
        "Jul'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.20",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.10",
          "val2": "-2.70",
          "chgp": "-14.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "1.40",
          "chgp": "-85.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.50",
          "val2": "7.20",
          "chgp": "-120.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.50",
          "val2": "0.60",
          "chgp": "-1,350.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-32,644.10%",
          "val2": "-20,538.50%",
          "chgp": "-1,210.56%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQstock-summary
Apr'25
Jan'25
Change(%)
Net Sales
0.00
0.10
-100.00%
Operating Profit (PBDIT) excl Other Income
-1.30
-1.30
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.00
-2.10
4.76%
Operating Profit Margin (Excl OI)
-158,553.50%
-26,430.20%
-13,212.33%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2025 is -100.00% vs 0.00% in Jan 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 4.76% vs 12.50% in Jan 2025

Annual Results Snapshot (Consolidated) - Jul'24stock-summary
Jul'24
Jul'23
Change(%)
Net Sales
0.10
0.20
-50.00%
Operating Profit (PBDIT) excl Other Income
-3.10
-2.70
-14.81%
Interest
0.20
1.40
-85.71%
Exceptional Items
-1.50
7.20
-120.83%
Consolidate Net Profit
-7.50
0.60
-1,350.00%
Operating Profit Margin (Excl OI)
-32,644.10%
-20,538.50%
-1,210.56%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jul 2024 is -50.00% vs 0.00% in Jul 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jul 2024 is -1,350.00% vs 106.67% in Jul 2023

stock-summaryCompany CV
About KDA Group, Inc. stock-summary
stock-summary
KDA Group, Inc.
Tour, Travel Related Services
KDA Group Inc, formerly AlliancePharma Inc, is a Canada-based company, which provides solutions and services to the pharmaceutical market. The Company operates in two segments: Pharmacy Services and Pharmaceutical Solutions. The Pharmacy services segment provides a range of services to pharmacies and pharmacists, including staffing, generic medication and related services. The Pharmaceutical Solutions segment provides a range of medical communications, training and other services to pharmaceutical companies in Canada. The Company holds interests in Pharmapar Inc., a generic pharmaceutical distribution company, and Agence L.I.V. Inc., a medical communication agency. The Company's subsidiaries include Campus Elitis Pharma Inc., Elitis Pharma Inc., Alliance Pharma Operations Inc., 9277396 Canada Inc., 9321-5317 Quebec Inc., Pro-J Pharma Inc., Biomed (2002) Inc. and Alliance Pharma SENCRL, which are engaged in provision of pharmacy services.
Company Coordinates stock-summary
Company Details
1351, rue Notre-Dame Est, Suite 300 , THETFORD MINES QC : G6G 0G5
Registrar Details